Morocco has established a regulatory framework and a managed supply chain for therapeutic cannabis, according to the Director General of ANRAC. This strategic shift aims to transition a previously illegal industry into a formal, regulated economic sector while integrating scientific validation into the rollout.
How is Morocco structuring its medical cannabis market?
The transition toward a legal therapeutic cannabis industry is now operational, with the Director General of ANRAC confirming that the country possesses both a ready regulatory framework and an available, supervised supply. According to local media reports, the industry is currently in a phase of formal structuring to ensure that production and distribution meet official standards.
What is the economic objective of the transition?
A primary driver of this policy is the desire to “green” a sector that has historically operated illegally. By moving cannabis production into a legal framework, Morocco intends to formalize the supply chain, effectively converting an illicit trade into a legitimate business vertical. This move is designed to bring the industry under state oversight and provide a legal pathway for producers and distributors.
How is science informing the therapeutic rollout?
To support the medical legitimacy of the industry, Morocco is integrating scientific discourse into its strategy. This was evidenced by the holding of the first scientific day dedicated to the therapeutic use of cannabis in Casablanca, according to public reports. This event signals a move to align the commercial rollout with clinical research and medical expertise.
